Editas Medicine shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Editas Medicine (EDIT) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Editas Medicine
Tip: Access up to 7 years of quarterly data
All positions including Editas Medicine held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Editas Medicine by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $268k | 109k | 2.47 |
| 2025-12-31 | $190k | 92k | 2.06 |
| 2025-09-30 | $300k | 86k | 3.48 |
| 2025-06-30 | $117k | 53k | 2.20 |
| 2025-03-31 | $51k | 44k | 1.17 |
| 2024-12-31 | $56k | 44k | 1.28 |
| 2024-09-30 | $222k | 65k | 3.43 |
| 2024-06-30 | $245k | 53k | 4.67 |
| 2024-03-31 | $369k | 50k | 7.42 |
| 2023-12-31 | $431k | 43k | 10.13 |
| 2023-09-30 | $342k | 44k | 7.81 |
| 2023-06-30 | $294k | 36k | 8.24 |
| 2023-03-31 | $255k | 35k | 7.26 |
| 2022-12-31 | $268k | 30k | 8.87 |
| 2022-03-31 | $476k | 25k | 19.04 |
| 2021-12-31 | $626k | 24k | 26.56 |
| 2021-09-30 | $1.8M | 43k | 41.08 |
| 2021-06-30 | $2.2M | 39k | 56.65 |
| 2021-03-31 | $1.3M | 32k | 41.99 |
| 2020-12-31 | $1.9M | 27k | 70.12 |
| 2020-09-30 | $415k | 15k | 28.09 |
| 2019-03-31 | $7.0M | 288k | 24.45 |
| 2018-12-31 | $12M | 525k | 22.75 |
| 2018-09-30 | $25M | 773k | 31.82 |
| 2018-06-30 | $28M | 784k | 35.83 |
| 2018-03-31 | $30M | 892k | 33.15 |
| 2017-12-31 | $28M | 898k | 30.73 |
| 2017-06-30 | $25M | 1.5M | 16.78 |
| 2017-03-31 | $31M | 1.4M | 22.32 |
| 2016-12-31 | $27M | 1.6M | 16.23 |
| 2016-09-30 | $25M | 1.9M | 13.48 |
| 2016-06-30 | $34M | 1.4M | 23.66 |
| 2016-03-31 | $47M | 1.4M | 33.49 |